NeuroPace (NPCE) Share-based Compensation (2020 - 2026)
NeuroPace's (NPCE) quarterly Share-based Compensation came in at $176000.0 in Q1 2026, down 93.3% year-on-year from $2.6 million in Q1 2025, and up 100.0% quarter-over-quarter from $88000.0 in Q4 2025.
NeuroPace (NPCE) Share-based Compensation (2020 - 2026) Analysis & Trends
NeuroPace's Share-based Compensation history runs 7 years deep, the most recent figure standing at $176000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation fell 93.3% year-over-year to $176000.0 in Q1 2026; TTM through Mar 2026 was -$1.9 million, a 166.72% decrease from a year earlier, with the FY2025 full-year figure at $543000.0, down 38.37% from the prior year.
- Share-based Compensation climbed to $176000.0 in Q1 2026 per NPCE's latest filing, from $88000.0 in the prior quarter.
- Across five years, Share-based Compensation topped out at $10.5 million in Q3 2022 and bottomed at -$6.9 million in Q4 2023.
- The 5-year median for Share-based Compensation is $176000.0 (2026), against an average of $600470.6.
- Biggest YoY gain for Share-based Compensation was 636.63% in 2022; the steepest drop was 613.37% in 2022.
- Year by year, Share-based Compensation stood at -$2.2 million in 2022, then slumped by 210.47% to -$6.9 million in 2023, then climbed by 2.07% to -$6.8 million in 2024, then jumped by 101.29% to $88000.0 in 2025, then soared by 100.0% to $176000.0 in 2026.
- Per Business Quant, the three latest NPCE Share-based Compensation figures stand at $176000.0 (Q1 2026), $88000.0 (Q4 2025), and $53000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 139.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 35.80 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 35.12 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | NeuroPace | 494.96 Mn | 440.98 Mn | 18.05 Mn | 176,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176,000.00 |
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Dec 31, 2025 | 88,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | -2.22 Mn |
| Jun 30, 2025 | -2.22 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Mar 31, 2025 | 2.63 Mn |
| Dec 31, 2024 | -6.80 Mn |
| Dec 31, 2024 | -6.80 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Sep 30, 2024 | 2.59 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Jun 30, 2024 | 4.44 Mn |
| Mar 31, 2024 | 649,000.00 |
| Mar 31, 2024 | 649,000.00 |
| Dec 31, 2023 | -6.94 Mn |
| Dec 31, 2023 | -6.94 Mn |